INVESCOFDS > AIM Investment Funds (Invesco Investment Funds)
Invesco Health Care Fund
$1.31B
Avg Monthly Net Assets
$1.44B
Total Assets
$58.51M
Total Liabilities
$1.38B
Net Assets
Invesco Health Care Fund is a Mutual Fund in AIM Investment Funds (Invesco Investment Funds)
from INVESCOFDS,
based in Texas,
United States of America.
The fund has five share classes
and monthly net assets of $1.31B.
On September 27th, 2024 it reported 80 holdings, the largest
being Eli Lilly and Co. (8.5%), Boston Scientific Corp. (5.8%) and UnitedHealth Group Inc. (5.2%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Ticker | Monthly Returns (2 years) |
|---|---|---|---|
| Invesco Health Care Fund Class A | C000000565 | GGHCX | |
| Invesco Health Care Fund Class C | C000000567 | GTHCX | |
| Invesco Health Care Fund Class R6 | C000188882 | GGHSX | |
| Invesco Health Care Fund Class Y | C000071224 | GGHYX | |
| Invesco Health Care Fund Investor Class | C000029647 | GTHIX |
Holdings
From latest NPORT-P, filed September 27th, 2024 for period ending July 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| AbbVie Inc. | Long | Equity-common | US | $29M | 158K | 2.12 |
| ADMA Biologics, Inc. | Long | Equity-common | US | $3M | 221K | 0.20 |
| Alcon Inc. | Long | Equity-common | CH | $9M | 92K | 0.63 |
| Alexandria Real Estate Equities, Inc. | Long | Equity-common | US | $3M | 28K | 0.23 |
| Alnylam Pharmaceuticals, Inc. | Long | Equity-common | US | $10M | 40K | 0.70 |
| Amgen Inc. | Long | Equity-common | US | $36M | 109K | 2.62 |
| argenx SE, ADR | Long | Equity-common | NL | $9M | 17K | 0.62 |
| Ascendis Pharma A/S, ADR | Long | Equity-common | DK | $8M | 63K | 0.61 |
| AstraZeneca PLC | Long | Equity-common | GB | $7M | 45K | 0.52 |
| AstraZeneca PLC, ADR | Long | Equity-common | GB | $50M | 632K | 3.63 |
| Axsome Therapeutics, Inc. | Long | Equity-common | US | $2M | 22K | 0.14 |
| Bio-Techne Corp. | Long | Equity-common | US | $7M | 88K | 0.52 |
| Blueprint Medicines Corp. | Long | Equity-common | US | $8M | 70K | 0.55 |
| Boston Scientific Corp. | Long | Equity-common | US | $80M | 1M | 5.80 |
| BridgeBio Pharma, Inc. | Long | Equity-common | US | $2M | 85K | 0.16 |
| BrightSpring Health Services, Inc. | Long | Equity-common | US | $3M | 263K | 0.24 |
| Brookdale Senior Living Inc. | Long | Equity-common | US | $4M | 502K | 0.28 |
| Bruker Corp. | Long | Equity-common | US | $3M | 50K | 0.25 |
| Cencora, Inc. | Long | Equity-common | US | $20M | 86K | 1.48 |
| Collegium Pharmaceutical, Inc. | Long | Equity-common | US | $2M | 56K | 0.16 |
| ConvaTec Group PLC | Long | Equity-common | GB | $2M | 822K | 0.18 |
| Cooper Cos., Inc. (The) | Long | Equity-common | US | $12M | 126K | 0.85 |
| CSL Ltd. | Long | Equity-common | AU | $2M | 11K | 0.16 |
| Cytokinetics, Inc. | Long | Equity-common | US | $5M | 85K | 0.36 |
| Danaher Corp. | Long | Equity-common | US | $58M | 211K | 4.24 |
| DexCom, Inc. | Long | Equity-common | US | $6M | 92K | 0.45 |
| Elevance Health, Inc. | Long | Equity-common | US | $47M | 89K | 3.43 |
| Eli Lilly and Co. | Long | Equity-common | US | $117M | 146K | 8.50 |
| Encompass Health Corp. | Long | Equity-common | US | $20M | 216K | 1.46 |
| Exelixis, Inc. | Long | Equity-common | US | $2M | 66K | 0.11 |
| Glaukos Corp. | Long | Equity-common | US | $7M | 63K | 0.54 |
| Halozyme Therapeutics, Inc. | Long | Equity-common | US | $5M | 93K | 0.37 |
| HCA Healthcare, Inc. | Long | Equity-common | US | $34M | 93K | 2.45 |
| HealthEquity, Inc. | Long | Equity-common | US | $9M | 120K | 0.68 |
| Icon PLC | Long | Equity-common | IE | $28M | 86K | 2.04 |
| IDEAYA Biosciences, Inc. | Long | Equity-common | US | $5M | 107K | 0.33 |
| IDEXX Laboratories, Inc. | Long | Equity-common | US | $4M | 8K | 0.26 |
| Immunovant, Inc. | Long | Equity-common | US | $2M | 78K | 0.16 |
| Insmed Inc. | Long | Equity-common | US | $7M | 103K | 0.54 |
| Inspire Medical Systems, Inc. | Long | Equity-common | US | $3M | 20K | 0.20 |
| Insulet Corp. | Long | Equity-common | US | $9M | 46K | 0.65 |
| Integer Holdings Corp. | Long | Equity-common | US | $8M | 66K | 0.57 |
| Intra-Cellular Therapies, Inc. | Long | Equity-common | US | $9M | 119K | 0.68 |
| Intuitive Surgical, Inc. | Long | Equity-common | US | $53M | 118K | 3.82 |
| Invesco Government & Agency Portfolio, Institutional Class | Long | Short-term investment vehicle | US | $16M | 16M | 1.18 |
| Invesco Private Government Fund | Long | Short-term investment vehicle | US | $16M | 16M | 1.16 |
| Invesco Private Prime Fund | Long | Short-term investment vehicle | US | $42M | 42M | 3.03 |
| Invesco Treasury Portfolio, Institutional Class | Long | Short-term investment vehicle | US | $31M | 31M | 2.24 |
| Krystal Biotech, Inc. | Long | Equity-common | US | $7M | 33K | 0.50 |
| Lantheus Holdings, Inc. | Long | Equity-common | US | $5M | 44K | 0.33 |
| Lonza Group AG | Long | Equity-common | CH | $13M | 20K | 0.96 |
| McKesson Corp. | Long | Equity-common | US | $59M | 96K | 4.28 |
| Medpace Holdings, Inc. | Long | Equity-common | US | $13M | 35K | 0.96 |
| Merck & Co., Inc. | Long | Equity-common | US | $51M | 453K | 3.72 |
| Merus N.V. | Long | Equity-common | NL | $5M | 85K | 0.33 |
| Natera, Inc. | Long | Equity-common | US | $14M | 137K | 1.02 |
| Neurocrine Biosciences, Inc. | Long | Equity-common | US | $11M | 75K | 0.77 |
| Novo Nordisk A/S, Class B | Long | Equity-common | DK | $41M | 310K | 2.98 |
| RadNet, Inc. | Long | Equity-common | US | $9M | 147K | 0.64 |
| Regeneron Pharmaceuticals, Inc. | Long | Equity-common | US | $49M | 45K | 3.56 |
| Repligen Corp. | Long | Equity-common | US | $3M | 17K | 0.20 |
| RxSight, Inc. | Long | Equity-common | US | $5M | 106K | 0.35 |
| Sarepta Therapeutics, Inc. | Long | Equity-common | US | $8M | 56K | 0.58 |
| Select Medical Holdings Corp. | Long | Equity-common | US | $6M | 146K | 0.42 |
| SpringWorks Therapeutics, Inc. | Long | Equity-common | US | $3M | 90K | 0.23 |
| Stryker Corp. | Long | Equity-common | US | $24M | 72K | 1.72 |
| Tarsus Pharmaceuticals, Inc. | Long | Equity-common | US | $3M | 120K | 0.21 |
| Tenet Healthcare Corp. | Long | Equity-common | US | $28M | 189K | 2.05 |
| Thermo Fisher Scientific Inc. | Long | Equity-common | US | $46M | 75K | 3.34 |
| TransMedics Group, Inc. | Long | Equity-common | US | $5M | 32K | 0.33 |
| Twist Bioscience Corp. | Long | Equity-common | US | $8M | 138K | 0.56 |
| Ultragenyx Pharmaceutical Inc. | Long | Equity-common | US | $2M | 50K | 0.16 |
| United Therapeutics Corp. | Long | Equity-common | US | $8M | 24K | 0.55 |
| UnitedHealth Group Inc. | Long | Equity-common | US | $72M | 125K | 5.23 |
| Vaxcyte, Inc. | Long | Equity-common | US | $7M | 89K | 0.51 |
| Vericel Corp. | Long | Equity-common | US | $4M | 83K | 0.31 |
| Vertex Pharmaceuticals Inc. | Long | Equity-common | US | $54M | 108K | 3.89 |
| Viking Therapeutics, Inc. | Long | Equity-common | US | $2M | 44K | 0.18 |
| Welltower Inc. | Long | Equity-common | US | $8M | 70K | 0.56 |
| Zoetis Inc. | Long | Equity-common | US | $8M | 45K | 0.59 |
Address
AIM Investment Funds (Invesco Investment Funds)
11 Greenway Plaza
Suite 1000
Houston
Texas
77046-1173
United States of America
Websites
Directors
Beth Ann Brown
Cynthia Hostetler
Eli Jones
Robert C. Troccoli
Teresa M. Ressel
Elizabeth Krentzman
Daniel S. Vandivort
Anthony J. LaCava, Jr.
Martin L. Flanagan
Joel W. Motley
Prema Mathai-Davis
Transfer Agents
Invesco Investment Services, Inc.
Pricing Services
Virtu Financial, Inc.
Lincoln Partners LLC
Refinitiv
Milliman, Inc.
Pricing Direct, Inc.
Lukka, Inc.
ICE Data Services, Inc.
Markit North America, Inc
Custodians
HSBC Bank Middle East Limited
Standard Chartered Bank DIFC Branch.
Stanbic Bank Zimbabwe Limited
State Street Bank International GmbH
Union Internationale de Banques
UniCredit Bank Hungary Zrt.
UniCredit Bank d.d.
UniCredit Bank Czech Republic and Slovakia, a.s.
UniCredit Banka Slovenija d.d.
Standard Chartered Bank Kenya Limited
Bank Handlowy w Warszawie S.A.
Standard Chartered Bank Cote d'Ivoire SA
Citibank Anonim Sirketi
Privredna Banka Zagreb d.d.
First Abu Dhabi Bank P.J.S.C.
Banco Nacional de Mexico S.A.
Standard Chartered Bank Uganda Limited
Banco de Chile
Standard Chartered Bank Tanzania Limited
HSBC BANK (CHINA) CO., LTD.
Saudi British Bank
UniCredit Bank Serbia JSC
UniCredit Bulbank AD
Ceskoslovenska obchodni banka a.s.
AS SEB banka
Morgan Stanley & Co. International PLC
Standard Chartered Bank (Taiwan) Limited
Standard Chartered Bank Botswana Limited
THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED
Citibank Kazakhstan JSC
Standard Chartered Bank Ghana Plc
BNP Paribas SA.
Deutsche Bank A.S.
Citibank (China) Co., Ltd.
Zagrebacka Banka d.d.
Credit Suisse (Switzerland) Ltd.
AS SEB Pank
Standard Bank Plc
Standard Chartered Bank Malaysia Berhad
HSBC SAUDI ARABIA LIMITED
HSBC BANK BERMUDA LIMITED
Joint Stock Company Bank of Georgia
JSC Citibank
Skandinaviska Enskilda Banken AB
Citibank Singapore Limited
DEUTSCHE BANK AG
UBS Switzerland AG
The Hongkong and Shanghai Banking Corporation Limited (HSBC)
Mizuho Bank, Ltd.
AO Citibank, Moscow
RAIFFEISEN BANK SH.A
AB SEB bankas
Banco Citibank (Panama) S.A.
FirstRand Bank
Standard Chartered Bangladesh
Standard Chartered Bank (Hong Kong) Limited
HSBC BANK OMAN SAOG
Cititrust Colombia S.A. Sociedad Fiduciaria
STANBIC IBTC BANK PLC
Citibank, N.A.
Banco Itau Uruguay S.A.
Standard Chartered Bank Zambia PLC
Citibank-Maghreb S.A.
Standard Bank Eswatini Limited
Standard Chartered Bank, Johannesburg branch
STANDARD CHARTERED BANK (THAI) PUBLIC COMPANY LIMITED
DZ BANK AG Deutsche Zentral-Genossenschaftsbank, Frankfurt am Main
Citibank Europe Public Limited Company
State Street Bank and Trust Company (Edinburgh)
UBS Securities LLC
Goldman Sachs & Co.
Citibank del Peru S.A.
HSBC Bank (Vietnam) Limited
Landsbankinn hf.
State Street Bank and Trust Co.
Standard Bank Namibia Limited
BANCO CITIBANK S A
CITIBANK N A
Deutsche Bank AG, Manila
UniCredit Bank Austria AG
STATE STREET TRUST COMPANY CANADA
CREDIT SUISSE SECURITIES (USA) LLC
Banco BCT S.A.
Standard Chartered Bank
Bank of America Merrill Lynch International Limited
Bank Hapoalim B.M.
China Construction Bank Corporation
Shareholder Servicing Agents
N/A
Admins
State Street Bank and Trust Co.
Brokers
COWEN AND COMPANY
MERRILL LYNCH, PIERCE, FENNER & SMITH INC.
UBS SECURITIES LLC
CITIGROUP GLOBAL MARKETS INC.
GOLDMAN, SACHS & CO.
INVESCO CAPITAL MARKETS, INC.
J.P. MORGAN SECURITIES LLC
MORGAN STANLEY & CO. LLC
OPPENHEIMER & CO. INC.
STIFEL, NICOLAUS & COMPANY, INCORPORATED